WHC is still in active development. Read this to understand our approach.
depiction of GGCSSNBKKAUURC-UHFFFAOYSA-N.svg
tripsit

sufentanil

Check on tripsit

psychonaut

Sufentanil

Check on psychonaut

isomerdesign

Sufentanil

Check on isomerdesign

pubchem

Sufentanil

Check on pubchem

druglab

Sufentanil

Check on druglab

drugmap

Sufentanil

Check on drugmap

wiki

Sufentanil

Check on wiki

Data

InChI: InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3

Synonyms: SUFENTANIL [MART.],SUFENTANIL [INN],L000580,R 30,730,BDBM94503, N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide,SUFENTANIL [MI], Sufentil (TN), Sufentanilum [INN-Latin],DB00708,NCGC00247355-01,N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide,N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide,cid_65494,UNII-AFE2YW0IIZ,N-[4-(Methoxymethyl)-1-{2-(2-thienyl)ethyl}-4-piperidinyl]-N-phenylpropanamide,C08022,ZINC538386,Sufentanyl,N-(4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl)-N-phenylpropanamide #,N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,Chronogesic,SCHEMBL26728, R-30730,SUFENTANIL [VANDF],N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]propionalnalide,R-30730,Sufentanil Base,citric acid;N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenyl-propionamide, Sufenta (TN), N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide, N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide,Dsuvia (brand name),Sufentanil [USAN:INN:BAN],Oprea1_246787,PDSP1_001741,SUFENTANIL,IDS-NS-001,2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidinyl]-N-phenylpropanamide,Zalviso,ARX 04,56030-54-7,PDSP2_001724,CHEBI:9316, Sulfentanil, Sufentanil (USAN/INN),Q417915,Sufentanilum [INN-Latin],Sufentanilum,Epitope ID:153513,Oprea1_120838, Sulfentanyl, Sufentanilum,N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,D05938,HSDB 6760,AFE2YW0IIZ,N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide,Sufenta (brand name),DTXSID6023604,Propanamide, N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-,SUFENTANIL [USAN],HY-13754,N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide,SUFENTANIL [EP MONOGRAPH], N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide,N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenyl-propanamide;2-oxidanylpropane-1,2,3-tricarboxylic acid,CHEMBL658,Sufentanil (USAN/INN), N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide,R 30730,Sufentanil, Sufentanil [USAN:BAN:INN], R 30730,SUFENTANIL [WHO-DD],ARX04,N-[4-(Methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidyl]-N-phenyl-propanamide,SUFENTANIL [HSDB],N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide,Propanamide, N-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenyl-, Sufentanyl,GTPL3534

Estimated data

Solubility: -4.206 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 81.8% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.